Characteristics of Acute Transfusion Reactions and its related factors in Cipto Mangunkusumo Hospital Jakarta, Indonesia

Pustika Amalia Wahidiyat; Elida Marpaung; Stephen Diah Iskandar

doi:10.22435/hsji.v10i1.1847

Pustika Amalia Wahidiyat
Elida Marpaung
Stephen Diah Iskandar

DOI: https://doi.org/10.22435/hsji.v10i1.1847

Keywords: blood transfusion, acute transfusion reaction, transfusion history, age

Abstract

Latar belakang: Reaksi transfusi akut (RTA) merupakan sekelompok kejadian yang tidak diinginkan akibat pemberian transfusi darah. Manifestasi dari RTA bervariasi dari yang ringan hingga mengancam nyawa. Saat ini, data mengenai reaksi transfusi di Indonesia masih sangat terbatas. Dalam studi ini, kami bertujuan untuk memberikan gambaran mengenai karakteristik RTA dan faktor-faktor yang mempengaruhinya.

Metode: Studi ini merupakan studi retrospektif yang melibatkan 288 subyek dengan RTA. Studi dilakukan di Rumah Sakit Dr. Cipto Mangunkusumo, dimulai sejak Januari hingga Desember 2017. RTA dikelompokkan berdasarkan sistem tubuh yang mengalami manifestasi, serta derajat manifestasinya.

Hasil: Sel darah merah merupakan produk darah utama yang ditransfusikan ke subyek, diikuti dengan konsentrat trombosit, plasma segar beku, dan kriopresipitat. Lima gejala utama dari RTA adalah gatal, demam/kenaikan suhu tubuh, menggigil, urtikaria, dan angioedema. Berdasarkan sistem tubuh yang terkena, umumnya RTA bermanifestasi sebagai gejala pada kulit (56.6%). Berdasarkan derajat manifestasinya, RTA umumnya dikategorikan dalam derajat ringan (55.9%). Anak-anak cenderung mengalami manifestasi yang ringan (64.8%) dan utamanya bermanifestasi pada kulit (65.4%). Riwayat transfusi mempengaruhi derajat RTA secara signifikan. RTA derajat sedang dan gejala konstitusional lebih banyak ditemukan pada subyek yang mendapat PRC dibanding produk darah lainnya.

Kesimpulan: Umumnya RTA bermanifestasi sebagai gejala dermatologi. Hanya sedikit kasus RTA yang disebabkan oleh reaksi inkompatibilitas. Manifestasi dan derajat RTA juga dipengaruhi oleh umur, riwayat transfusi, dan jenis komponen darah.

Kata kunci: Transfusi darah, reaksi transfusi akut, riwayat transfuse, usia

Abstract

Background: Acute transfusion reactions (ATRs) are a group of adverse events caused by blood transfusions. Manifestations of ATRs vary from mild to life threatening. At present, data about transfusion reactions in Indonesia are still limited. In this study, we aim to determine the characteristics of ATRs and its related factors.

Methods: This was a retrospective study of 288 subjects with ATRs. The study was conducted in Cipto Mangunkusumo Hospital, started from January to December 2017. ATRs were categorized based on the body systems affected and degree of manifestations.

Results: Packed red cells (PRC) was the predominant blood product (51.4%) which was transfused to subjects, followed by thrombocyte concentrate (TC), fresh frozen plasma (FFP), and cryoprecipitate. Five most common predominant symptoms of ATRs were pruritus/itch, febrile/increased temperature, chills, transient urticaria, and angioedema. Based on the affected body systems, the majority of ATRs manifested as dermatologic symptoms (56.6%). Based on the degree of manifestations, the majority of ATRs were categorized as mild degree (55.9%). Children tended to have milder symptoms (64.8%), which mostly manifested as dermatologic symptoms (65.4%). History of transfusion affected the degree of ATR significantly. Moderate degree of ATRs and constitutional symptoms were found more common in subjects who received PRC than other blood products.

Conclusion: Most of ATRs manifest as dermatologic symptoms, which represent allergic reactions. Only a small portion of ATRs are caused by incompatibility reactions. The manifestation and degree of ATRs are also affected by age, history of transfusion, and type of blood components.

Keywords: Blood transfusion, acute transfusion reaction, transfusion history, age

References

Hendrickson JE, Roubinian NH, Chowdhury D, Brambilla D, Murphy EL, Wu Y, et al. Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication. Transfusion. 2016;56:2587-96.

Azizi S, Tabary SZ, Soleimani A. Prevalence of acute blood transfusion reactions in Mazandaran Heart Center, Sari, Iran, 2010-2012. Med Arch. 2014;68:137-9.

Payandeh M, Zare ME, Kansestani AN, et al. Descriptions of acute transfusion reactions in the teaching hospitals of Kermanshah University of Medical Sciences, Iran. Int J Hematol Oncol Stem Cell Res. 2013;7:11-6.

Torres R, Kenney B, Tormey CA. Diagnosis, treatment, and reporting of adverse effects of transfusion. Lab Medicine. 2012;43:217-31.

Jain A, Kaur R. Hemovigilance and blood safety. Asian J Transfus Sci. 2012;6:137-8.

Kato H, Uruma M, Okuyama Y, et al. Incidence of transfusion-related adverse reactions per patient reflects the potential risk of transfusion therapy in Japan. Am J Clin Pathol. 2013;140:219-24.

Sharma DK, Datta S, Gupta A. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative. Indian J Pharmacol.2015;47:370-374.

Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program. 2016;2016:446-51.

Karafin MS, Bruhn R, Westlake M, Sullivan MT, Bialkowski W, Edgren G, et al. Demographic and epidemiologic characterization of transfusion recipients from four U.S. regions: evidence from the REDS-III Recipient Database. Transfusion. 2017;57:2903-13.

Bassi R, Aggarwal S, Bhardwaj K, Thakur KK. Patterns of adverse transfusion reactions in a tertiary care centre of North India: a step towards hemovigilance. Indian J Hematol Blood Transfus. 2017;33:248-53.

Sahu S, Hemlata, Verma A. Adverse events related to blood transfusion. Indian J Anaesth. 2014;58:543-51.

Hirayama F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol. 2013;160:434-44.

Garraud O, Hamzeh-Cognasse H, Cognasse F: Platelets and cytokines: how and why? Transfus Clin Biol. 2012;19:104-8.

Lin JS, Tzeng CH, Hao TC, et al. Cytokine release in febrile non-haemolytic red cell transfusion reactions. Vox Sang. 2002;82:156–60.

Chang C-C, Lee T-C, Su M-J, et al. Transfusionassociated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of pre-storage versus post-storage leuko reduction. Oncotarget. 2018;9:4385-94.

Strobel E: Hemolytic transfusion reactions. Transfusion Med Hemother. 2008;35:346-53.

Hod EA, Sokol SA, Zimring JC, et al. Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis. Int J Clin Exp Pathol. 2009;2:71-82.

Goodell PP, Uhl L, Mohammed M, et al. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion. Am J Clin Pathol. 2010;134:202-6.

Oakley FD, Woods M, Arnold S, et al. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products. Transfusion. 2015;55:563-70.

Kato H, Nakayama T, Uruma M, et al. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history. Vox Sang. 2015; 108:243-50.

Gwaram BA, Borodo MM, Dutse Al, Kuliya-Gwarzo A. Pattern of acute blood transfusion reactions in Kano, North-Western Nigeria. Niger J Basic Clin Sci. 2012;9:27-32.

Pedrosa AKKV, Pinto FJM, Lins LDB, Deus GM. Blood transfusion reactions in children: associated factors. J Pediatr (Rio J).2013;89:400-6.

Cho J, Choi SJ, Kim S, Alghamdi E, Kim HO. Frequency and pattern of noninfectious adverse transfusion reactions at a tertiary care hospital in Korea. Ann Lab Med. 2016;36:36-41.

Sharma RR, Marwaha N. Leukoreduced blood components: advantages and strategies for its implementation in developing countries. Asian J Transfus Sci.2010;4:3-8.